Clinical trial Recruiting at 1 site Interventional Ages 18 and up

High-flow oxygen therapy for patients weaning off mechanical ventilation

Official title: Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning From Invasive Mechanical Ventilation

Run by Erasmus Medical Center · NCT06776939 · Data updated 2026-11-12

This study tests if high-flow oxygen therapy can help patients with tracheostomies breathe easier and clear mucus better while they are transitioning off mechanical ventilation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations1 site (Rotterdam)
StatusRecruiting
StartedDecember 31, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 1, 2026
Trial IDNCT06776939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are currently weaning from mechanical ventilation and have a tracheostomy.

Probably not a fit

Patients with longstanding tracheostomies or those with specific medical histories such as mucociliary or neuromuscular diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-flow tracheal oxygen (HFTO) on airway mucus viscosity and respiratory effort in patients with tracheostomies who are transitioning off invasive mechanical ventilation. The research aims to determine if HFTO can reduce sputum thickness and improve respiratory support during the weaning process compared to conventional oxygen therapy. By focusing on these physiological parameters, the study seeks to enhance patient outcomes during a critical phase of recovery from respiratory failure.

Why it matters

Potential benefit: If successful, this approach could improve the weaning process from mechanical ventilation, reducing respiratory complications and enhancing patient comfort.

How similar studies have gone: Previous studies have shown promising results with high-flow oxygen therapy in similar contexts, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* Age ≥18 years
* Weaning from mechanical ventilation with tracheostomy

Exclusion Criteria:

* Longstanding tracheostomy, defined as tracheostomy being present prior to current hospital admission
* Tracheostomy primarily indicated for chronic upper airway obstruction or to secure airway patency due to persistent stupor/coma
* Chronic positive pressure respiratory support at home (excluding night-time continuous positive airway pressure for sleep apnea)
* Mucociliary disease in medical history (e.g. cystic fibrosis, pulmonary ciliary dyskinesia)
* Neuromuscular disease in medical history (excluding ICU-acquired weakness)
* Contra-indication placement oesophageal balloon for measurement of PES, such as:

  * Fractures in mandibular, orbital or ethmoid bone or skull base
  * Esophageal varices or surgery in medical history
  * Severe bleeding disorders
* Hemoptysis in 72 hours prior to the first disconnection session. Clinically relevant hemoptysis is defined as hemoptysis requiring tracheal/endobronchial or radiologic intervention, or administration of pro-coagulating drugs such as tranexamic acid.

Where it's running

  • Erasmus Medical Center
    Rotterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.